Nautilus Biotechnology, Inc. (NAUT)
2.38
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
2.57
+0.19
(+7.98%)
After-Hours: 05:42
Nautilus Biotechnology Shareholders Equity (Quarterly) : 144.42M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cytek Biosciences, Inc. | 327.64M |
| Agilent Technologies, Inc. | 6.908B |
| Inotiv, Inc. | 77.10M |
| Bio-Rad Laboratories, Inc. | 6.851B |
| Bruker Corp. | 2.449B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 177.78M |
| Total Liabilities (Quarterly) | 33.36M |
| Debt to Equity Ratio | 0.1999 |
| Current Ratio | 11.85 |
| Net Debt Paydown Yield | 0.07% |